ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF - USD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.35 USD | +0.79% |
|
-0.39% | -0.55% |
Investment objective
The iShares Nasdaq US Biotechnology UCITS ETF seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ.
| Name |
Price
|
Change
|
5d. change
|
1st Jan change
|
Weight
| |
|---|---|---|---|---|---|---|
| 422.8 USD | +0.90% | +5.41% | +3.91% | 8.46% | ||
| 973.8 USD | +0.60% | +1.76% | +10.87% | 7.85% | ||
| 310.2 USD | -0.87% | -0.37% | +7.68% | 7.84% | ||
| 65.96 USD | +2.14% | +1.82% | -18.58% | 7.77% | ||
| 221.5 USD | -0.56% | +1.83% | -14.40% | 3.86% | ||
| 117.3 USD | -4.39% | -6.15% | +17.96% | 3.85% | ||
| 150.5 USD | -0.59% | -1.22% | -21.39% | 2.51% | ||
| 110.5 USD | -0.74% | -6.27% | -20.62% | 2.31% | ||
| 81.03 USD | -0.84% | -1.71% | -15.96% | 1.87% | ||
More news
In partnership with
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/24/10 | 6.35 | +0.79% | 1 |
| 08/24/08 | 6.3 | -0.60% | 485 |
| 07/24/07 | 6.338 | +0.44% | 452 |
| 06/24/06 | 6.31 | -1.02% | 43,537 |
| 03/24/03 | 6.375 | +3.39% | 1,497 |
Other stock markets
Delayed Quote Swiss Exchange
Last update May 10, 2024 at 09:05 pm IST
More quotesDescription
| IE00BYXG2H39 | |
|---|---|
| Total Expense Ratio | 0.35% |
| Asset Class | |
| Sector | |
| Size | |
| Currency | |
| Provider | |
| Underlying | NASDAQ Biotechnology Net Total Return Index - USD |
Features and characteristics
| Jurisdiction | |
| Replication Method | |
| Replication Model | |
| Date of creation |
19/10/2017
|
| Dividend Policy | |
| Geographical Focus |
AuM evolution ( 30/04/2024 )
| AuM (EUR) | 0 M€ |
|---|---|
| AuM 1M | 0 M€ |
| AuM 3 months | 0 M€ |
| AuM 6 months | 0 M€ |
| AuM 12 months | 0 M€ |
- Stock Market
- ETF
- BTEC ETF